(b)(4).Information regarding patient identifier, date of birth, age, gender, weight, race, and ethnicity were not provided.Section e.1: the initial reporter phone: (b)(6).The initial reporter email address was not available / reported.Based on complaint information, the device is not available to be returned for analysis.Lake region medical performed a review of the device history records relative to the manufacturing, inspection, and packaging of the lot 8028680.The history record indicates this product was final inspection tested at lake region medical and was determined to be acceptable.Product analysis cannot be conducted as the product was not returned for analysis.No determination of causes and possible contributing factors could be made.As such, the investigation will be closed.With the information available and without the complaint product available to be returned for analysis, the reported issue documented in the complaint cannot be confirmed through functional evaluation and analysis.Based on the manufacturing documentation review, there is no indication that the event is related to the device manufacturing process.Assignment of root cause for the event remains speculative and inconclusive, based on the limited information provided and without the return of the complaint sample; however, it is possible that clinical and procedural factors, including device manipulation / interaction may have contributed to the reported failure.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective / preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
The healthcare professional reported that during a vascular stent placement procedure, the physician released the stent, a 4.5mm x 22mm enterprise® vascular reconstruction device (vrd) (enc452212 / 8028680) after balloon dilation.It was observed that three (3) proximal markers of the stent converged and could not be opened.It was reported that the physician ¿continued to release one enterprise 2 stent to complete the surgery.¿ there was no report of any negative patient impact.
|
Manufacturer¿s ref.No: (b)(4).The purpose of this mdr submission is to include the additional event information received on 08-oct-2023.[additional information]: the cerenovus sales representative provided additional information.Per the additional information, the target vessel was the basilar artery.The procedure was basilar artery balloon dilation and stent implantation.There were no vessel factors that may have contributed to the reported incomplete expansion.There was no evidence of obstructed blood flow due to the event.The temperature indicated label on the inner pouch had been checked and found to be within acceptable criteria.The information indicated that the balloon catheter used during the procedure was a gateway balloon catheter.The microcatheter used was a prowler select plus (606s255x / 31008204) the same microcatheter was used to complete the procedure.There was no resistance during the advancement of the stent.Per the additional information, clarification of the event description, ¿doctor continued to release one enterprise 2 stent to complete the surgery is as follows: the original stent was implanted in the patient and could not be removed, [the] physician released the second stent in patient.¿ the second stent implanted in the patient was a 4mm x 23mm enterprise 2 stent (encr402312).The event did not result in any clinically significant delay in the procedure.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|